The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Abstract | BACKGROUND: STUDY DESIGN: 52-week, open-label, phase 3, randomized, controlled trial for safety-profile assessment. SETTING & PARTICIPANTS: Maintenance dialysis patients with serum phosphorus levels ≥6.0 mg/dL after washout of prior phosphate binders. INTERVENTION: OUTCOMES: MEASUREMENTS: RESULTS: LIMITATIONS: CONCLUSIONS:
|
Authors | Peter N Van Buren, Julia B Lewis, Jamie P Dwyer, Tom Greene, John Middleton, Mohammed Sika, Kausik Umanath, Josephine D Abraham, Shahabul S Arfeen, Isai G Bowline, Gil Chernin, Stephen Z Fadem, Simin Goral, Mark Koury, Marvin V Sinsakul, Daniel E Weiner, Collaborative Study Group |
Journal | American journal of kidney diseases : the official journal of the National Kidney Foundation
(Am J Kidney Dis)
Vol. 66
Issue 3
Pg. 479-88
(Sep 2015)
ISSN: 1523-6838 [Electronic] United States |
PMID | 25958079
(Publication Type: Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Acetates
- Calcium Compounds
- Chelating Agents
- Ferric Compounds
- Inflammation Mediators
- Phosphates
- Polyamines
- ferric citrate
- Sevelamer
- Calcium
- calcium acetate
|
Topics |
- Acetates
(therapeutic use)
- Aged
- Calcium
(blood)
- Calcium Compounds
(therapeutic use)
- Chelating Agents
(therapeutic use)
- Female
- Ferric Compounds
(therapeutic use)
- Humans
- Hyperphosphatemia
(drug therapy)
- Inflammation Mediators
(metabolism)
- Kidney Failure, Chronic
(metabolism, therapy)
- Male
- Middle Aged
- Phosphates
(metabolism)
- Polyamines
(therapeutic use)
- Renal Dialysis
- Sevelamer
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|